Meet Dr. Manvich
Meet Dr. Manvich
Dr. Daniel Manvich, Ph.D.
Associate Professor, Department of Neuroscience
Rowan-Virtua School of Osteopathic Medicine
Virtua Health College of Medicine & Life Sciences of Rowan University
Science Center, Room A204
Office Phone: 856-566-6424
E-mail: manvich@rowan.edu
I received my B.A. in Biopsychology from Tufts University in 2003. While at Tufts, I worked in the laboratory of Dr. Klaus Miczek, where I assisted in research evaluating the impact of intermittent social stress on cocaine intake. After graduating from Tufts, I worked as a research technician for two years in the Preclinical Pharmacology Laboratory at McLean Hospital, Harvard Medical School in Belmont MA, where I was co-mentored by Dr. Jack Bergman and Dr. Carol Paronis.
I went on to earn my Ph.D. in Neuroscience from Emory University in 2011. Working under the mentorship of Dr. Leonard Howell, my dissertation studies characterized the impact of highly-selective serotonin 5-HT2C receptor agonists and antagonists on the neurochemical and behavioral effects of cocaine. I then continued my training as a postdoctoral fellow in the laboratory of Dr. David Weinshenker at Emory University School of Medicine, where I led three distinct research projects. My primary research project, which was ultimately supported by a K99/R00 award, focused on developing and characterizing a novel model of psychosocial stress-induced drug seeking in rodents.
In February 2018, I established my independent laboratory here at Rowan in what is now the Department of Neuroscience in the Rowan-Virtua School of Osteopathic Medicine. Continuing on with the work I began as a postdoc, my primary line of research is currently aimed at identifying the neural circuitry underlying drug-seeking behavior that is elicited by psychosocial stress. More broadly, I am interested in understanding the neurobiolgical mechanisms by which individuals exhibit active or passive coping strategies in response to social threat, and how these traits are linked to vulnerability or resilience to substance abuse and other neuropsychiatric disorders. Other projects in the lab include studying sex differences and estrous cycle effects on opioid reinforcement and opioid seeking, examining mechanisms underlying stress-induced enhancement of opioid reinforcement, and assessing the effects of potential new Opioid Use Disorder pharmacotherapeutics on mesolimbic dopamine neurotransmission. We also have an exciting new collaboration with colleagues at the Cooper Medical School of Rowan University aimed at understanding how certain adulterants in the illicit opioid supply modulate the behavioral and physiological effects of opioid compounds.
Use the links below to view Dr. Manvich's publication history: